Scrapie strain replication in the nerve growth factorinduced, differentiated PC12 cell culture system was examined. Differences in replication between mousederived agents were demonstrated, with the 139A scrapie strain yielding 100-to 1000-fold higher levels of infectivity than the ME7 scrapie strain. Replication was not detected in PC 12 cells infected with either the hamster-derived 263K or rat-derived 139R scrapie strains. Studies on the neurotransmitters in infected PC12 cells demonstrated that the adrenergic pathway was unchanged but the cholinergic pathway was altered. Furthermore, the degree of alteration correlated with the level of scrapie strain replication.
Scrapie strain replication in the nerve growth factorinduced, differentiated PC12 cell culture system was examined. Differences in replication between mousederived agents were demonstrated, with the 139A scrapie strain yielding 100-to 1000-fold higher levels of infectivity than the ME7 scrapie strain. Replication was not detected in PC 12 cells infected with either the hamster-derived 263K or rat-derived 139R scrapie strains. Studies on the neurotransmitters in infected PC12 cells demonstrated that the adrenergic pathway was unchanged but the cholinergic pathway was altered. Furthermore, the degree of alteration correlated with the level of scrapie strain replication.
Comparison of infectivity titres and enzymatic changes in ME7-infected PC12 cells with those in Chandler agent-infected mouse neuroblastoma cells suggests that the significant changes in neurotransmitter levels in cultures exhibiting low titres of infectivity involve factors in addition to strain replication. The variation in the range of scrapie strain replication in PC 12 cells is discussed in relationship to species barrier, cell targeting, genetic susceptibility and species strain specificity. These studies further emphasize the value of the PC 12 cell model system in examining the scrapie strain-host cell interaction and in addition support the concept of variation among scrapie strains.
Scrapie, a natural disease of sheep and goats, is the archetype of a group of transmissible degenerative central nervous system diseases which are caused by unconventional agents (Gajdusek, 1977) . The existence of scrapie strains was established many years ago, beginning with observations in natural scrapie that differences existed in clinical manifestations and in the areas of the brain that showed the most intense histopathological changes. Subsequently, evidence for the existence of scrapie strain variation has come from exhaustive long-term studies of serially passaged scrapie from natural and experimental sources in inbred mouse strains (Dickinson, 1976) . In mice, more than 20 scrapie strains have been identified based on differences in biological, biochemical and histopathological parameters Kascsak et al., 1985 Kascsak et al., , 1986 Kascsak et al., , 1991 . More recently, the establishment of distinct scrapie strains in hamsters has also been described (Kimberlin et al., 1987 (Kimberlin et al., , 1989 Carp et al., 1990; . However, the existence of scrapie strains in in vitro cell systems has not been demonstrated.
We have previously described (Rubenstein et al., 1984 (Rubenstein et al., , 1990 ) the ability of the 139A scrapie strain to replicate to relatively high titres, for a tissue culture system, in nerve growth factor (NGF)-induced, differentiated PC 12 cells. Furthermore, it has been shown that 139A scrapie strain replication in NGF-treated PC 12 cells can cause decreases in the enzymes associated with the cholinergic pathway, choline acetyltransferase (CHAT) and acetylcholinesterase (ACHE). The adrenergic pathway is not affected, as demonstrated by unchanged tyrosine hydroxylase (TH) and dopa decarboxylase activities. In this study we have extended these findings, and demonstrate that only certain scrapie strains are capable of replication in NGF-treated PC12 cells and that the extent of the enzymatic changes observed is a function of the particular strain's ability to replicate.
The 139A mouse-adapted scrapie strain and the 263K hamster-adapted scrapie strain were kindly provided by Dr R. H. Kimbedin (SARDAS, Edinburgh, U.K.). The ME7 mouse-adapted scrapie strain was a gift from Dr A. G. Dickinson (formerly of the AFRC Neuropathogenesis Unit, Edinburgh, U.K.). As a source of inoculum, stock pools of brain homogenate obtained after inoculation with the mouse-adapted scrapie strains were established after at least four serial passages in C57BL/6J mice, whereas the hamster-adapted scrapie strain 263K was maintained in LVG/LAK hamsters.
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The rat-adapted 139R scrapie strain was the generous gift of Dr R. H. Kimberlin. Its origin and initial passage history have been described previously (Kimberlin et al., 1987) . This agent was then passaged in Lewis albino white rats several times in our laboratory to ensure its stability prior to use in our studies.
PC12 cells were grown in the absence of NGF, plated and maintained in the presence of NGF, and exposed to the above scrapie strains or normal brain homogenate as described previously . In addition to PC12 cells, mouse neuroblastoma cells were also used in this study. These cells were either infected (cell line 325-B6) with the Chandler (139A) scrapie strain or mock-infected (cell line 321-16). The cells exposed to 139A were persistently infected throughout five or six continuous passages. These cells were established, maintained and analysed as described previously (Race et al., 1987 (Race et al., , 1988 . Prior to use, the two cell lines were cloned and confirmation of scrapie infection was obtained by Western blot analysis of PrP27-30.
The processing of cells and determination of CHAT, AChE and TH activities were performed as described previously . Briefly, cells were harvested at various times post-infection (p.i.) and washed in ice-cold PBS pH 7-4. Cell lysates were prepared by homogenization in ice-cold 100 mM-sodium phosphate buffer pH 7-4 containing 0.5 ~o Triton X-100. ChAT activity was measured using the method of Fonnum (1975) , AChE activity was assayed by the method of Ellman et al. (1961) and TH activity was measured according to Waymire et al. (197 I) . In all of our enzyme studies, each experiment was performed twice in triplicate.
The ability and extent to which the scrapie agents were able to replicate in NGF-treated PC12 cells were dependent on the scrapie strain used. For the mouse and rat scrapie strains, the brain homogenates used as the source of infectivity were all diluted.such that the cells were infected with the same amount of agent (m.o.i. of 1). For the hamster-adapted 263K strain, brain homogenates were diluted such that an m.o.i, of 10 was used. As indicated in this study and also shown previously (Rubenstein et al., 199 l) ,the 139A scrapie strain replicated in differentiated PC12 cells and achieved infectivity titres in the range of 1 LD5o/cell. The ME7 scrapie strain has also been shown to replicate in these cells. However, the infectivity titres from ME7-infected cultures were found to be 0.01 to 0.001 LD50/cell. The 263K hamsteradapted scrapie strain did not replicate in differentiated PC12 cells. Unexpectedly, the 139R rat-adapted scrapie strain did not replicate in NGF-treated PC12 cells (which are of rat origin) during the entire course of the experiment (42 days), as demonstrated by negative bioassay results in both rats and mice. In view of previously reported results on the ability of 139A infection to alter neurotransmitter-related enzyme activity in these cells , the ability of other scrapie strains to cause similar alterations was studied. ChAT activity was assayed as a marker for the cholinergic system and TH as an indicator of the adrenergic pathway. As shown in Fig. 1, 139A infection of NGF-treated PC12 cells caused a decrease in ChAT activity. This change was first detected at 21 days p.i., the time at which 139A scrapie strain replication can first be measured in these cells (Rubenstein et al., 1990) . Furthermore, the decrease in ChAT activity continued and increased in magnitude as the time after infection increased. However, exposure to normal mouse brain homogenate does not affect enzyme activity during the same time periods. These findings are similar to those reported previously for 139A-infected cells. Studies of ChAT activity in NGF-treated PC12 cells infected with the ME7 scrapie strain also showed a decrease in enzyme activity (Fig. 1) . The decrease was first detected at a later time p.i. (28 day s) than that in 139A-infected cultures (21 days). In addition, the decrease in activity was not as dramatic by the end of the experiment (48~ decrease for ME7, 84~ decrease for 139A at 42 days p.i.). In comparing 139A and ME7, the differences in the reduction of enzymatic activity did not reflect the greater differences in infectivity titres. Exposure of NGF-treated PC 12 cells to either the 263K or 139R scrapie strain did not result in any changes in ChAT activity during the entire course of the experiment (Fig. 1) .
We next examined TH activity in NGF-treated PC12 cells at various times after infection with the same four scrapie strains used above. As reported previously and demonstrated in this study, 139A infection did not alter TH activity throughout the entire course of the experiment (42 days) when compared to cultures exposed to normal mouse brain homogenate [TH activity (nmol/min/mg protein): 5 h p.i. 2.00 + 0.08 (normal brain homogenate), 2-18 + 0.12 (139A scrapie strain); 42 days p.i. 2.01 + 0-10 (normal brain homogenate), 2.37 + 0.09 (139A scrapie strain)]. Similarly, infection with ME7, 263K or 139R did not alter TH activity (2.15 + 0.01, 2.04 + 0.07 and 2.22 + 0.11, respectively, at 42 days p.i.) when compared to either normal brain homogenate or the 139A scrapie strain infection at any time during the course of the experiment.
We next determined whether the scrapie-induced effects on the PC12 ceils were specific for this cell line or could be observed in other neuronal cell lines capable of supporting scrapie replication. For these studies we used mouse neuroblastoma ceils persistently infected with the Chandler scrapie strain (cell line 325-B6) and, as a control, cells exposed to normal brain homogenate (cell line 321-16). As reported previously (Kimberlin et al., 1987) , the major scrapie strain isolated upon continuous passage of the Chandler agent is 139A. The scrapieinfected mouse neuroblastoma cells have been well characterized (Race et al., 1987 (Race et al., , 1988 and those cell clones which contain PrP27-30, as shown by Western blotting, also contain scrapie infectivity (data not shown). Infectivity studies (Race et al., 1988) have demonstrated titres of 0.01 to 0-001 LD50/cell. As shown in Table 1 , ChAT activity was decreased by 32~ and AChE activity by 45~ in scrapie-infected cultures as compared to the controls. In contrast, TH activity in the infected cultures was similar to that seen in controls. These results indicate that although the same pathways are affected in both cell lines examined, the extent of these changes differs.
The key finding of this study is that differences in the properties of scrapie strains are found in the simplified system represented by cultures of differentiated PC12 cells. These cultures contain a single, cloned cell type, and the mechanics of the infection procedure are easily controlled. In comparing results obtained with 139A and ME7, it should be emphasized that the infecting material was prepared in an identical manner from a single inbred mouse strain (C57BL/6J) following at least four serial passages of the scrapie strains in that mouse strain. Both scrapie strains replicated in this system but the yield of infectivity from 139A-infected cultures was much greater than that from ME7-infected cultures. Furthermore, the reduction in the activity of enzymes in the cholinergic neurotransmitter pathway was much greater in cells infected with 139A than in those infected with ME7. The results indicate that a component of the infectious agent other than that dictated by the primary sequence of the host-coded PrP molecule must have directed the differences seen in these scrapie strain-host cell interactions.
The failure of the hamster-passaged 263K strain to replicate or induce changes in cholinergic enzymes in ratderived PC12 cells may be a function of an in vitro effect of the species barrier phenomenon. For unconventional infectious agents the species barrier is manifested in vivo in the following manner. The incubation period on passage of an agent from one species to another is extremely long for the initial passage and quickly decreases on subsequent passages to a comparatively low and stable level (Dickinson, 1976; Kimberlin, 1979) . The development of transgenic mice expressing the hamster PrP gene (Scott et al., 1989; Prusiner et al., 1990) has demonstrated that PrP is a controlling factor in delineating species barriers in mice and hamsters. The mechanism whereby PrP controls the species barrier is not clear. Nor is it apparent how the species barrier would affect in vitro agent-induced effects, but either agent attachment to cells or replication within cells could be altered.
The species barrier would not appear to play a role in the failure of the 139R strain to replicate in or affect PC12 cells. The 139R scrapie strain was developed by repeated serial passage of the 139A scrapie strain in outbred albino rats (Kimberlin et al., 1987) . Passage of this rat-adapted strain back into mice resulted in a mouse scrapie strain indistinguishable in its biological properties from the 139A strain passaged solely in mice. This would suggest that the informational molecule of the 139A scrapie strain was unchanged on passage in rats. However, the biochemical properties of PrP obtained from 139A-infected mice and 139A-infected rats differ with respect to resistance to proteinase K degradation (data not shown), perhaps due to differences in their primary sequence, conformational alterations and/or association with other components. If one assumes that
PrP is part of the infectious agent, then differences in its structure could affect attachment to and/or processing within exposed ceils. In previous studies examining scrapie agent replication in vitro, the m.o.i, has been shown to be a critical factor (Butler et al., 1988) . In those studies, scrapie agent replication could not be demonstrated unless an m.o.i, of 10 to 100 was used even in the absence of a species barrier. A contributing factor to the inability to demonstrate 139R replication in PCI2 cells could have been the low m.o.i, used. One of the defining characteristics of scrapie strains is their differing capacity to target different cells, probably neurons, within the brain . It is quite possible that 139A and 139R differ with regard to their ability to target the neuron-derived PC12 cell, resulting in inefficient infection by 139R.
In vivo studies have demonstrated the important role of at least one host gene which affects agent susceptibility in a differential manner. For example, it is known that in mice the host gene that controls scrapie incubation, Sinc, can produce markedly different incubation periods for different scrapie strains. For example, the s7s7 allele of the Sinc gene produces a comparatively short incubation period for the ME7 scrapie strain but a very long incubation period for the 22A strain and, at an extreme, mice with this allele are not susceptible to the 87V scrapie strain (Dickinson et al., 1984) . It is possible that PC12 cells, which were derived from the New England Deaconess Hospital strain of rats, carry a gene that makes them susceptible to the 139A strain but comparatively resistant to the 139R strain, which was passaged in outbred Lewis albino rats.
It is interesting that the effect on neurotransmitter pathways in scrapie-infected mouse neuroblastoma cells is similar to that on rat PCI2 cell lines; those enzymes associated with cholinergic pathways were decreased, whereas an enzyme associated with the adrenergic pathway was unaffected. It would be interesting to determine whether this is a generalized effect of scrapie on various types of neuronal cells or whether the effect has a restricted neuronal cell range. Another issue that remains to be resolved is whether similar effects on neurotransmitter pathways can play a role in the induction of disease in vivo.
The replication of the 139A scrapie strain in PC12 cells yielded between 1 and 4 infectious units/cell, although 1 infectious unit/cell was more common. This could be a result of a few cells producing many infectious units or all cells producing comparable units/cell. In the context of the 139A-PCI2 system, we cannot assess the relationship between changes in cholinergic enzymes and the replication of the agent in particular cells. However, results with the ME7-PC12 system and with Chandler agent-infected mouse cells, do shed light on this issue. In each of these examples the yield of infectivity per culture is quite low, 0.01 to 0.001 LDs0/cell. Thus, at any given time very few cells are actively producing infectious agent. Despite this, there is a 30 to 50~ reduction in ChAT activity in both systems and a 45 ~ reduction in AChE activity in infected mouse cells. This indicates that in these cultures many cells not producing infectious agent at a given time are affected. There are two possible explanations for this finding. (i) The few cells that are producing infectious agent are the only cells infected, and these cells produce a diffusible molecule that affects cholinergic pathways in other cells in the culture, or (ii) many cells are infected but at a given time few are producing infectious agent. Cells infected but not producing agent are affected, at least to the extent that their cholinergic enzyme activities are decreased. Cell cloning studies by Race et al. (1988) support the second explanation in that they show that nearly every neuroblastoma cell is infected even when infectivity yields are in the order of 0-01 to 0.001 infectious units/cell. It would appear that scrapie can produce a latent or abortive infection of neuroblastoma cells that can affect macromolecular synthesis within these cells at a time far removed from when they are producing infectious agent.
Further studies utilizing this in vitro model system will lead to a better understanding of scrapie strain-host cell interactions. This model will also aid in examining the parameters that influence not only infection and replication of the unconventional agents, but also the mechanisms associated with cellular dysfunction leading to neuropathology.
